Table 1.
Baseline characteristics.
| iStent Inject®
(Mean ± SD) |
iStent Inject® W (Mean ± SD) |
p-Value | |
|---|---|---|---|
| n | 35 | 32 | 0.40 |
| age | 69.86 ± 6.85 | 70.20 ± 10.30 | 0.87 |
| sex | |||
| M | 17 (48.5%) | 13 (40.6%) | 0.62 |
| F | 18 (51.5%) | 19 (59.4%) | 0.63 |
| number of previous operations | selective laser trabeculoplasty: 2 (5.7%) | selective laser trabeculoplasty: 13 (40%) | <0.01 * |
| cyclophotocoagulation: 1 (2.9%) | cyclophotocoagulation: 0 | 0.93 | |
| trabeculectomy: 1 (2.9%) | trabeculectomy: 0 | 0.93 | |
| visual field (MD) | 11.76 ± 2.3 dB | 6.15 ± 5.32 dB | 0.04 * |
| RNFL-OCT | 175.9 ± 53.1 µm | 191.6 ± 39.6 µm | 0.25 |
| BMO-OCT | 187.6 ± 72.1 µm | 211.6 ± 79.9 µm | 0.41 |
| preoperative IOP | 15.17 ± 3.78 mm Hg | 16.08 ± 3.27 mm Hg | 0.29 |
| number of glaucoma agents | 2.63 ± 0.97 | 2.69 ± 1.03 | 0.73 |
n: number of eyes, M: male, F: female, MD: main defects, SD: standard deviation, * significant result, dB: decibel, IOP: intraocular pressure.